Aptorum Group Limited Class A Ordinary Shares earnings per share and revenue
On 18. Dez. 2025, APM reported earnings of -- USD per share (EPS) for Q2 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Citius Pharmaceuticals Inc. Common
Report Date
26. Dez. 2025 For Q4 25
Estimate
-$0.49
Aktuell
-
Überraschung
-
FAQ
What were Aptorum Group Limited Class A Ordinary Shares's earnings and revenue for the latest quarter Q2 2025?
For Q2 2025, Aptorum Group Limited Class A Ordinary Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Aptorum Group Limited Class A Ordinary Shares's Q2 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Aptorum Group Limited Class A Ordinary Shares expected to report next?
The next earning report is scheduled for 28. Apr. 2026.
What are the forecasts for Aptorum Group Limited Class A Ordinary Shares's next earnings report?
Based on --
analysts, Aptorum Group Limited Class A Ordinary Shares is expected to report EPS of -- and revenue of -- for Q4 2025.